Edition:
United States

CAS Medical Systems Inc (CASM.OQ)

CASM.OQ on NASDAQ Stock Exchange Capital Market

2.28USD
10:49am EDT
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.28
Open
$2.30
Day's High
$2.34
Day's Low
$2.28
Volume
13,984
Avg. Vol
46,134
52-wk High
$2.70
52-wk Low
$0.59

Latest Key Developments (Source: Significant Developments)

Cas Medical Systems Q1 Loss Per Share $0.07
Thursday, 10 May 2018 08:00am EDT 

May 10 (Reuters) - CAS Medical Systems Inc ::CASMED REPORTS FIRST-QUARTER 2018 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.07.QUARTERLY NET SALES FROM CONTINUING OPERATIONS $5.4 MILLION VERSUS $4.5 MILLION.  Full Article

Casmed Reports Q4 Loss Per Share $0.07
Wednesday, 14 Mar 2018 08:00am EDT 

March 14 (Reuters) - Cas Medical Systems Inc ::CASMED REPORTS 2017 FOURTH-QUARTER AND FULL-YEAR FINANCIAL RESULTS.Q4 LOSS PER SHARE $0.07.Q4 SALES ROSE 11 PERCENT TO $5.1 MILLION.CASH, CASH EQUIVALENTS, AND AVAILABLE BORROWINGS UNDER LINE-OF-CREDIT WERE $7.5 MILLION AS OF DECEMBER 31, 2017.‍CONFIDENT IN ACHIEVING 2018 FINANCIAL OUTLOOK INTRODUCED IN JANUARY​.  Full Article

CasMed Sees Q4 2017 Sales About $5.1 Million
Thursday, 4 Jan 2018 09:20am EST 

Jan 4 (Reuters) - Cas Medical Systems Inc ::CASMED REPORTS PRELIMINARY NET SALES FOR THE 2017 FOURTH QUARTER.SEES Q4 2017 SALES ABOUT $5.1 MILLION.SEES FY 2017 SALES ABOUT $18.7 MILLION.- ‍EXPECTATIONS FOR 2018 INCLUDE LOW-TEENS PERCENTAGE INCREASE IN U.S. FORE-SIGHT SALES.  Full Article

‍Long Focus Capital Management Reports 6.9 Pct Passive Stake In CAS Medical Systems
Friday, 1 Dec 2017 04:15pm EST 

Dec 1 (Reuters) - Cas Medical Systems Inc ::‍LONG FOCUS CAPITAL MANAGEMENT LLC REPORTS 6.9 PERCENT PASSIVE STAKE IN CAS MEDICAL SYSTEMS INC ​AS OF NOVEMBER 29 - SEC FILING.  Full Article

CASMED reports Q3 earnings per share $0.10
Thursday, 9 Nov 2017 08:00am EST 

Nov 9 (Reuters) - Cas Medical Systems Inc :CASMED reports third-quarter 2017 financial results.Q3 earnings per share $0.10.Q3 sales $4.5 million versus $5.0 million.Cas Medical Systems Inc sees 2017 ‍total fore-sight oximetry sales to be flat to down slightly​.Cas Medical Systems Inc sees 2017 ‍total fore-sight sensor sales to increase in low single-digit percentages​.Cas Medical Systems Inc - ‍Company affirmed its financial guidance for 2017​.Cas Medical Systems Inc - "‍We are continuing on a path to cash flow breakeven, which we expect to reach in early 2019​".  Full Article

CAS Medical Systems Q2 loss per share $0.09
Tuesday, 8 Aug 2017 08:37am EDT 

Aug 8 (Reuters) - Cas Medical Systems Inc :CASMED reports second-quarter 2017 financial results.Q2 loss per share $0.09.Q2 sales $4.6 million.Revises full-year financial guidance​.Sees ‍2017 total fore-sight oximetry sales to be flat to down slightly​.Sees ‍2017 total fore-sight sensor sales to increase in low single-digit percentages​.  Full Article

Casmed sells non-invasive blood pressure monitoring product line to Suntech Medical
Wednesday, 26 Jul 2017 08:00am EDT 

July 26 (Reuters) - CAS Medical Systems Inc ::Casmed sells non-invasive blood pressure monitoring product line to Suntech Medical.Deal for $4.5 million in cash.  Full Article

Casmed reports Q1 loss per share of $0.08
Wednesday, 3 May 2017 08:00am EDT 

May 3 (Reuters) - Cas Medical Systems Inc :Casmed reports first-quarter 2017 financial results.Q1 loss per share $0.08.Q1 sales $5.2 million versus $5.5 million.Sees 2017 total fore-sight sales to increase in mid-single-digit percentages.Sees 2017 total fore-sight disposable sensor sales to increase approximately 10 pct.Sees 2017 U.S. Fore-Sight sensor sales to increase in mid-teens percentages.Sees 2017 U.S. Monitor placements to increase in mid-teens percentages.  Full Article

Thomas Patton reports 5.6 pct stake in CAS Medical Systems Inc
Tuesday, 4 Apr 2017 07:35am EDT 

Cas Medical Systems Inc :Thomas M. Patton reports 5.6 percent stake in CAS Medical Systems Inc, as of March 10, 2017 - SEC filing.  Full Article

CAS Medical Q4 loss per share $0.07
Thursday, 9 Mar 2017 08:00am EST 

CAS Medical Systems Inc : Casmed reports 2016 fourth-quarter and full-year financial results . Q4 loss per share $0.07 . Q4 sales rose 3 percent to $5.5 million .CAS Medical Systems Inc - expecting 2017 total fore-sight sales increasing in mid-teen percentages.  Full Article

BRIEF-FDA Clears CASMED's Fore-Sight Tissue Oximetry OEM Module

* CAS MEDICAL SYSTEMS INC - EXPECTS A FILING WITH FDA FOR 510(K) CLEARANCE ON ITS FIRST OEM MODULE COMBINATION PRODUCT BEFORE END OF 2018 Source text for Eikon: Further company coverage: